Form D · Biotechnology
Molecular Assemblies, Inc.
San Diego, CA · CIK 0001693170
Offering snapshot reported Sep 26, 2022 · SEC filing
- Reported sold
- $25.9M Offering amount: $40M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 7, 2021 As reported in this filing
Fundraising history
Reported soldDates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.
What changed?
Latest filing versus its linked predecessor, where available.
- Reported sold$20,130,000 → $25,946,575
- Reported investors6 → 14
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 26, 2022 | Amendment | $25,946,575 | $5,816,575vs Sep 22, 2021 | 14 | SEC filing |
| Sep 24, 2021 | Amendment | $14,147,646 | $10,428,837vs Oct 11, 2019 | 22 | SEC filing |
| Sep 22, 2021 | Initial | $20,130,000 | No comparison | 6 | SEC filing |
| Sep 29, 2020 | Amendment | $6,514,195 | $2,795,386vs Oct 11, 2019 | 10 | SEC filing |
| Jul 10, 2020 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Oct 11, 2019 | Initial | $3,718,809 | No comparison | 8 | SEC filing |
| Jul 11, 2018 | Amendment | $6,477,744 | $1,940,000vs Aug 9, 2017 | 36 | SEC filing |
| Aug 9, 2017 | Initial | $4,537,744 | No comparison | 28 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-414209
Source: Form D, filed Sep 26, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Helge Bastian | Director |
| Curt Becker | Director, Executive |
| J. William Efcavitch, Ph.D. | Director, Executive |
| Sean Freeman | Director, Executive |
| David Hwang | Director |
| Michael J. Kamdar | Director, Executive |
| John Nicols | Director |
| Todd Peterson | Director |
| Jeffrey Sampson, Ph.D. | Director |
| Joe H. Smith | Director |
| Larry Stambaugh | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
9880 Campus Point Dr. Suite 110
San Diego, CA, 92121
San Diego, CA, 92121